Bayer Roundup Settlement News Today 2026: The $7.25 Billion Deal Is Still Waiting on One Judge
Quick Answer
- The $7.25 billion settlement is real and under final review in Missouri state court.
- Payouts range from $10,000 to $165,000 for qualifying non-Hodgkin lymphoma claims .
- The opt-out deadline passed June 4, 2026, and no new claim deadline has been posted.
You want the latest. Here it is, stripped of press-release polish: nothing dramatic happened this week. The deal is signed, the hearing is done, and the judge has not ruled.
What did happen is more subtle and more important for your claim. Bayer won the first Roundup trial since the Supreme Court narrowed liability . That verdict does not change the settlement terms. It changes the leverage. Bayer now walks into the final approval fight with a fresh jury win in its pocket.
This article covers where the settlement stands, what the payout tiers actually pay, who is still eligible, and the one date that already passed for anyone who wanted out. The surprising part: the settlement fund is not sitting in a bank account. Bayer pays in declining capped installments over up to 21 years .
The Facts
| Item | Detail |
|---|---|
| Case | Proposed nationwide Roundup class settlement (Missouri state court) |
| Status | Final approval hearing held September 14, 2026; ruling pending |
| Fund Size | Up to $7.25 billion over up to 21 years |
| Est. Per Person | $10,000 to $165,000 for NHL claims, depending on severity and age |
| Opt-Out Deadline | June 4, 2026 (passed) |
| Claim Registration | Not yet open; contingent on final approval and appeals |
| Administrator | Professional claims administrator named in court filings |
| Proof Needed | NHL diagnosis, exposure history, treatment records |
Is the Bayer Roundup Settlement Real or Still Pending?
The Bayer Roundup settlement is real as a signed agreement, but it is not final as a legal matter. A Missouri state court judge held the final approval hearing on September 14, 2026, and had not issued a ruling as of late October .
The distinction matters. “Final approval” from a trial judge is not the end. Bayer’s own quarterly statement says the settlement “does not become final and effective until all appeal procedures have been concluded, which could take several years” .
Objecting plaintiffs already tried to move the case to federal court and failed. A federal judge sent it back to Missouri in June, ruling that only the defendant has removal authority . The objectors have appealed that decision. Every appeal is another delay before money moves.
Reality Check: No one texts you a settlement check. The claims administrator is not calling for your bank details. Filing is free, and any website charging a fee to “release your Roundup funds” is running a scam on your search.
How Much Will the Roundup Settlement Pay Per Person?
The Roundup settlement pays $10,000 to $165,000 per qualifying non-Hodgkin lymphoma claim, based on cancer severity, age at diagnosis, and whether exposure was occupational or residential . One report cited potential awards as high as $198,000 for certain cases .
There is no single “average.” The tiers are structured to pay more to younger claimants and those with stronger exposure proof. A landscaper diagnosed at 45 is in a different category than a homeowner diagnosed at 78.
Here is what the publicly reported ranges look like:
| Claim Type | Reported Range | Key Factor |
|---|---|---|
| Top-tier NHL claims | Up to $165,000 average | Younger age, occupational exposure |
| Mid-tier claims | Varies widely | Mixed proof and severity |
| Higher-end cited figure | Up to $198,000 | Certain qualifying cases |
| Attorney fee request | $675 million | Separate from class member payouts |
The $675 million fee request has drawn criticism from objectors who say lawyers are being paid before cancer victims . The judge will decide whether to approve, reduce, or reject that request alongside the settlement itself.
Key Takeaway: The range is real, but the fund is not a lump sum. Bayer pays in declining installments over up to 21 years, so the headline number is a ceiling, not a check.
Who Qualifies for the Roundup Settlement?
You may qualify if you were exposed to Roundup before February 17, 2026, and have been diagnosed with non-Hodgkin lymphoma, or receive that diagnosis within 16 years after the settlement becomes effective .
The class covers current and future NHL claims regardless of legal theory. That is broader than earlier Roundup settlements, which resolved only existing cases. The deal is designed to wipe out the category of lawsuits, not just the ones on file.
One cutoff already passed. If you filed a lawsuit or signed a tolling agreement before February 13, 2026, you qualify for specific expedited award categories that later claimants do not . If you did not take legal action before that date, you are still in the class, but your path to payment runs through the general claims process.
Bayer faces roughly 65,000 pending claims across state and federal courts . The settlement is meant to absorb nearly all of them.
Can I Still Opt Out of the Roundup Settlement?
No. The opt-out deadline passed on June 4, 2026 . If you did not file an exclusion request by that date, you are bound by the settlement’s terms for the claims it covers.
That means you cannot file a separate Roundup lawsuit for the same NHL injury if you stayed in the class. Your remedy is the settlement, not a courtroom.
The opt-out process was complicated by the Supreme Court’s June ruling in Monsanto v. Durnell, which limited failure-to-warn claims. Bayer and class counsel asked for and received a delay in the final approval hearing to process opt-out revocation requests from people who changed their minds after that ruling .
The hearing moved from July to September 14. The judge has not ruled since.
What Does the Recent Bayer Trial Win Mean for the Settlement?
Bayer won a unanimous jury verdict on October 29, 2026, in a St. Louis trial brought by three women who claimed Roundup caused their cancer . The jury rejected design defect and negligence claims in about two hours .
The verdict does not change the settlement terms. It changes the negotiating atmosphere. Bayer’s general counsel said the win “should send a strong signal that plaintiffs who wish to pursue claims in the court system” after the Durnell ruling will face serious challenges .
For you, the practical read is this: the settlement is now the safest path to any recovery. The plaintiffs who rejected it and went to trial lost. The ones still waiting for a judge’s signature are betting the deal gets approved.
Bayer’s stock rose 3.7% on the verdict . The company is treating the win as validation. Whether the judge treats it as irrelevant to settlement fairness is a separate question.
What Happens Next in the Roundup Settlement?
Here is the expected sequence, with confirmed dates where they exist:
September 14, 2026: Final approval hearing held. No ruling issued as of October 31 .
Expected late 2026 or early 2027: Judge issues final approval ruling.
Expected 2027 onward: Appeals filed and processed. This is the main bottleneck .
After appeals resolve: Claim registration opens and claims are processed.
Over up to 21 years: Bayer pays declining capped installments .
The appeals timeline is not controlled by the judge. Objectors have already appealed the federal remand decision . More appeals are expected after final approval. Bayer’s own language about “several years” is the most honest estimate available.
Frequently Asked Questions
Is the Bayer Roundup settlement approved?
Not yet. The final approval hearing was held September 14, 2026, and the judge has not ruled.
How much will I get from the Roundup settlement?
Payouts range from $10,000 to $165,000 for qualifying NHL claims, depending on severity, age, and exposure type.
When will Roundup settlement checks mail?
No date is confirmed. Checks cannot move until final approval and all appeals are resolved.
Can I still file a Roundup claim?
The opt-out deadline passed June 4, 2026. Claim registration has not opened. Watch the court docket.
What if I develop NHL after the settlement?
The class covers diagnoses within 16 years after the settlement becomes effective.
Did Bayer just win a Roundup trial?
Yes. A St. Louis jury ruled for Bayer on October 29, 2026, in the first trial since the Durnell ruling.
Who is paying the settlement?
Bayer’s Monsanto unit, in declining capped annual payments totaling up to $7.25 billion.
The Bottom Line
The Roundup settlement is not a rumor and not a scam. It is a $7.25 billion agreement waiting on one judge’s signature and then a stack of appeals. The payout range is real. The timeline is not.
Your move now is to find your medical records and document your Roundup exposure history. The opt-out door closed in June. The claim door has not opened. Watch the Missouri court docket, not the ads.
